Literature DB >> 3103474

Predictors of interepisode symptoms and relapse in affective disorder patients treated with lithium carbonate.

P J Goodnick, R R Fieve, A Schlegel, N Baxter.   

Abstract

For 98 affective disorder patients receiving lithium prophylaxis for a mean of 45 months, number of interepisode symptoms correlated with relapse rate. Response to prophylaxis appeared highly determined by prelithium frequency of episodes and duration of lithium treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103474     DOI: 10.1176/ajp.144.3.367

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

1.  Long-term outcome of lithium prophylaxis in patients initially classified as complete responders.

Authors:  M Maj; R Pirozzi; D Kemali
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Subsyndromal states in bipolar disorder.

Authors:  Dushad Ram; Daya Ram
Journal:  Indian J Psychiatry       Date:  2010-10       Impact factor: 1.759

3.  Mindfulness-based cognitive therapy versus psychoeducational intervention in bipolar outpatients with sub-threshold depressive symptoms: a randomized controlled trial.

Authors:  Guillermo Lahera; Carmen Bayón; Maria Fe Bravo-Ortiz; Beatriz Rodríguez-Vega; Sara Barbeito; Margarita Sáenz; Caridad Avedillo; Rosa Villanueva; Amaia Ugarte; Ana González-Pinto; Consuelo de Dios
Journal:  BMC Psychiatry       Date:  2014-08-15       Impact factor: 3.630

4.  A systematic review and meta-analysis of clinical predictors of lithium response in bipolar disorder.

Authors:  T P Hui; A Kandola; L Shen; G Lewis; D P J Osborn; J R Geddes; J F Hayes
Journal:  Acta Psychiatr Scand       Date:  2019-06-30       Impact factor: 6.392

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.